NHS Genomics Hub Tests for New Anti-Cancer Drug Variant
Routine genetic testing to guide use of chemotherapy has incorporated a new “African” gene variant which could potentially help save the lives of Black and ethnic minority cancer patients.
Latest
Comment and analysis on key issues on ethnic health inequalities in health and social care.
Statement in response to hospital failings which led to a woman’s death from sickle cell
Responding to the inquest into the death of Irene Dzifa King Arthur, which heard that the 47‑year‑old who had sickle cell, might have survived had she received an urgent blood transfusion, Dr Carl Reynolds, Sickle Cell Medical Advisor at the NHS Race and Health Observatory, said:
Observatory Chief Executive confirmed as member of Maternity Taskforce
Observatory Chief Executive confirmed as member of Maternity Taskforce.
Invitation to Tender: Development Partner for the NHS Race and Health Observatory (RHO) Website and Health Action Resource Platform (HARP)
The NHS Race and Health Observatory seeks a highly capable software development organisation to take over the maintenance of the NHS RHO website and ongoing development, maintenance, and strategic evolution of the Health Action Resource Platform.
Mental health services must act to reverse the traumatic effects of racism
Our new report finds that racism not only causes trauma and mental illness but also prevents people from getting the right support for their mental health.
Statement from the NHS Race and Health Observatory in response to the interim report from Baroness Amos, Chair of the independent National Maternity and Neonatal Investigation
Responding to interim findings of Maternity and Neonatal Services in England published today, Professor Habib Naqvi, chief executive, NHS Race and Health Observatory, said:
New Programme to Tackle NHS Bullying, Harassment and Abuse Announced
A 16-month programme aimed at closing the ethnicity gap in bullying, harassment and abuse claims has been announced by the NHS Race and Health Observatory.
New resource to help tackle suicide risk in Gypsy, Roma and Traveller communities
A series of three short films released today, and supported by the NHS Race and Health Observatory, explore the spate of suicides amongst Britain’s 600,000 Gypsy, Roma and Traveller people
Partnership announced to improve diversity in patient access to genomic medicine in the NHS
Generations of Black, Asian and minority ethnic communities could reap the benefits of genomic and precision medicine following the commissioning of a new study.
Observatory engages on actions to tackle race disparities in health
The NHS Race and Health Observatory (RHO) today (8 November) engaged on its key ambitions and future priorities to tackle racial health disparities across England.
Statement in response to the CQC State of Care report
Responding to the State of Care report, Sam Rodger, Assistant Director, Policy and Strategy of the NHS Race and Health Observatory said:
Observatory commissions pioneering work to tackle barriers faced by children with sickle cell disease
Barriers faced by children and young people living with sickle cell as they transition from NHS paediatric to adult health care providers are set to be explored and tackled.
Statement in response to Lord Darzi review
Responding to the Darzi Review findings, Professor Habib Naqvi, chief executive of the NHS Race and Health Observatory said:
Statement in response to new Health Services Safety Investigations Body (HSSIB) report on NHS temporary workforce and patient safety
Response to today’s HSSIB investigation report which highlights how discrimination is preventing NHS temporary workers speaking up.
Open statement in response to racist and violent protests
We strongly condemn the racist violence that we have all witnessed over the last few days and our thoughts remain with the families and friends who are grieving loved ones.
Review to explore cancer drug limitations due to ethnic gene variations
Wider genetic testing could save lives, reduce costs and help thousands of Black, Asian and ethnic minority patients at risk of severe side effects resulting from chemotherapy drugs.